OPO accountability dossier

Texas Organ Sharing Alliance (TOSA)

TXSACMS Tier 2

OPTN Region 4 — central and south Texas (San Antonio and Austin regions)

CMS performance & status

CMS 2023 OPO Interim Annual Public Aggregated Performance Report, Table 5b: 2021 tier = Tier 2 (donation category 2E, transplant category 2B; 2019/2020/2021 = 3/3/2).

This OPO is graded Tier 2 (2023 Assessment (CY2021 data)) under the CMS Conditions for Coverage outcome measures. Tier 2 is above the median but below the top quartile; these OPOs must compete to retain their service area.

2023 OPO Interim Annual Public Aggregated Performance Report (CMS), Table 5b

Findings naming this OPO (1)

Consent gap (1)

Individual OPOs self-reported pancreata-for-research increases ranging from 10% to 6,400% in a single year (2021-2022)

Donor Alliance; Lifebanc; Indiana Donor Network; OneLegacy; Texas Organ Sharing Alliance; and other surveyed OPOs

In responses cited by the Senate Finance Committee 'Operation Transplant' report, OPOs reported widely varying single-year (2021-2022) increases in pancreata placed for research: Donor Alliance reported a 6,400% increase, Lifebanc 2,000%, Indiana Donor Network 747%, Lifeline of Ohio 392%, OneLegacy 390%, LifeQuest 267%, Texas Organ Sharing Alliance 216%, Mid-America Transplant 56%, NJ Sharing Network 89%, and Kentucky Organ Donor Affiliates 10%. The report flags these increases as evidence of possible gaming of CMS performance metrics.

Operation Transplant: Examining the Need for Oversight in the Organ Donation System (Senate Finance Committee staff report), footnote 30

Every item is institution-level public record, source-linked; no patient, donor, or family is named. A Tier or finding here repeats the government's own assessment of an organization holding a public monopoly. Back to OrganWatch.